Last 12 months
Inside the activity.
0 purchase rows · 7 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 1 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 3 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 10, 2019 Filed Oct 15, 2019 20:17 UTC |
Jain Mudit K.Director
|
GrantCommon Stock | 227 | $54.84 | $12,448.68 |
DisclosureSEC source: 0001104659-19-054157 · a4.xml · nonDerivative · entry 1 Jain Mudit K. · CIK 0001584404 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,597 F1 · shares: Represents shares of common stock received in lieu of cash fees pursuant to the Issuer's Non-Employee Director Compensation Policy. Read SEC document |
| October 07, 2019 Filed Oct 8, 2019 22:31 UTC |
Ban RandyChief Commercial Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 700 | $1.47 Strike: $1.47 | $1,029.00 |
DisclosureSEC source: 0001104659-19-053429 · a4.xml · derivative · entry 3 Ban Randy · CIK 0001737127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,690 Underlying: Common Stock · 700 shares Expires 2022-05-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option is fully vested and exercisable. Read SEC document |
| October 07, 2019 Filed Oct 8, 2019 22:31 UTC |
Ban RandyChief Commercial Officer
|
SaleCommon Stock | 700 | $58.30 | $40,810.00 |
DisclosureSEC source: 0001104659-19-053429 · a4.xml · nonDerivative · entry 2 Ban Randy · CIK 0001737127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 900 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $58.23 to $58.32. The reporting person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| October 07, 2019 Filed Oct 8, 2019 22:31 UTC |
Ban RandyChief Commercial Officer
|
Exercise / conversionCommon Stock | 700 | $1.47 | $1,029.00 |
DisclosureSEC source: 0001104659-19-053429 · a4.xml · nonDerivative · entry 1 Ban Randy · CIK 0001737127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,600 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 30, 2019 Filed Oct 2, 2019 23:16 UTC Amendment |
Buchholz RichardChief Financial Officer
|
Exercise / conversionCommon Stock | 3,800 | $0.94 | $3,572.00 |
DisclosureSEC source: 0001104659-19-052723 · a4a.xml · nonDerivative · entry 3 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,706 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · acquired: This amendment to the Form 4 originally filed on October 2, 2019 is being filed to correct the filing code in column 4 of Table I to reflect an acquisition of shares. Read SEC document |
| September 30, 2019 Filed Oct 2, 2019 23:16 UTC Amendment |
Buchholz RichardChief Financial Officer
|
Exercise / conversionCommon Stock | 9,200 | $0.94 | $8,648.00 |
DisclosureSEC source: 0001104659-19-052723 · a4a.xml · nonDerivative · entry 2 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,906 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · acquired: This amendment to the Form 4 originally filed on October 2, 2019 is being filed to correct the filing code in column 4 of Table I to reflect an acquisition of shares. Read SEC document |
| September 30, 2019 Filed Oct 2, 2019 23:16 UTC Amendment |
Buchholz RichardChief Financial Officer
|
Exercise / conversionCommon Stock | 15,000 | $2.07 | $31,050.00 |
DisclosureSEC source: 0001104659-19-052723 · a4a.xml · nonDerivative · entry 1 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,706 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · acquired: This amendment to the Form 4 originally filed on October 2, 2019 is being filed to correct the filing code in column 4 of Table I to reflect an acquisition of shares. Read SEC document |
| September 30, 2019 Filed Oct 2, 2019 20:33 UTC |
Buchholz RichardChief Financial Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 3,800 | $0.00 Strike: $0.94 | $0.00 |
DisclosureSEC source: 0001104659-19-052579 · a4.xml · derivative · entry 10 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,215 Underlying: Common Stock · 3,800 shares Expires 2026-12-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option, representing a right to purchase a total of 6,015 shares, vested and became exercisable as to 25% of the underlying shares on January 1, 2018 and the remaining 75% of the underlying shares have vested or will continue to vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates. As of September 30, 2019, the option was vested and exercisable as to 4,009 of the underlying shares. Read SEC document |
| September 30, 2019 Filed Oct 2, 2019 20:33 UTC |
Buchholz RichardChief Financial Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 9,200 | $0.00 Strike: $0.94 | $0.00 |
DisclosureSEC source: 0001104659-19-052579 · a4.xml · derivative · entry 9 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,589 Underlying: Common Stock · 9,200 shares Expires 2027-03-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option, representing a right to purchase a total of 15,789 shares, vested and became exercisable as to 25% of the underlying shares on April 1, 2018, and the remaining 75% of the underlying shares have vested or will continue to vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates. As of September 30, 2019, the option was vested and exercisable as to 9,539 of the underlying shares. Read SEC document |
| September 30, 2019 Filed Oct 2, 2019 20:33 UTC |
Buchholz RichardChief Financial Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $2.07 | $0.00 |
DisclosureSEC source: 0001104659-19-052579 · a4.xml · derivative · entry 8 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,706 Underlying: Common Stock · 15,000 shares Expires 2024-05-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option is fully vested and exercisable. Read SEC document |
| September 30, 2019 Filed Oct 2, 2019 20:33 UTC |
Buchholz RichardChief Financial Officer
|
Exercise / conversionCommon Stock | 3,800 | $0.94 | $3,572.00 |
DisclosureSEC source: 0001104659-19-052579 · a4.xml · nonDerivative · entry 3 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,706 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 30, 2019 Filed Oct 2, 2019 20:33 UTC |
Buchholz RichardChief Financial Officer
|
Exercise / conversionCommon Stock | 9,200 | $0.94 | $8,648.00 |
DisclosureSEC source: 0001104659-19-052579 · a4.xml · nonDerivative · entry 2 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,906 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 30, 2019 Filed Oct 2, 2019 20:33 UTC |
Buchholz RichardChief Financial Officer
|
Exercise / conversionCommon Stock | 15,000 | $2.07 | $31,050.00 |
DisclosureSEC source: 0001104659-19-052579 · a4.xml · nonDerivative · entry 1 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,706 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 24, 2019 Filed Sep 26, 2019 20:32 UTC |
Herbert Timothy P.Director · CEO and President
|
SaleCommon Stock | 2,056 | $67.46 | $138,697.76 |
DisclosureSEC source: 0001104659-19-051559 · a4.xml · nonDerivative · entry 3 Herbert Timothy P. · CIK 0001737136 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Indirect · By family trust Disclosed balance after: 74,624 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $67.35 to $67.63. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: Shares held by the Timothy P. Herbert 2013 Family Irrevocable GST Trust U/A/D November 27, 2013. Read SEC document |
| September 24, 2019 Filed Sep 26, 2019 20:32 UTC |
Herbert Timothy P.Director · CEO and President
|
SaleCommon Stock | 1,482 | $65.64 | $97,278.48 |
DisclosureSEC source: 0001104659-19-051559 · a4.xml · nonDerivative · entry 2 Herbert Timothy P. · CIK 0001737136 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Indirect · By family trust Disclosed balance after: 76,680 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.35 to $66.18. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: Shares held by the Timothy P. Herbert 2013 Family Irrevocable GST Trust U/A/D November 27, 2013. Read SEC document |
| September 24, 2019 Filed Sep 26, 2019 20:32 UTC |
Herbert Timothy P.Director · CEO and President
|
SaleCommon Stock | 1,462 | $64.80 | $94,737.60 |
DisclosureSEC source: 0001104659-19-051559 · a4.xml · nonDerivative · entry 1 Herbert Timothy P. · CIK 0001737136 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Indirect · By family trust Disclosed balance after: 78,162 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $64.32 to $65.23. The reporting person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: Shares held by the Timothy P. Herbert 2013 Family Irrevocable GST Trust U/A/D November 27, 2013. Read SEC document |
| September 20, 2019 Filed Sep 24, 2019 20:36 UTC |
NELSON MARILYN CDirector
|
SaleCommon Stock | 30,000 | $67.09 | $2,012,700.00 |
DisclosureSEC source: 0001104659-19-051208 · a4.xml · nonDerivative · entry 1 NELSON MARILYN C · CIK 0001199894 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 270,517 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $67.00 to $67.35. The Reporting Person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: Shares held by GDN Holdings, LLC, of which the Reporting Person is the managing member. Read SEC document |
| September 12, 2019 Filed Sep 16, 2019 20:48 UTC |
Ban RandyChief Commercial Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 10,000 | $1.47 Strike: $1.47 | $14,700.00 |
DisclosureSEC source: 0001104659-19-050284 · a4.xml · derivative · entry 5 Ban Randy · CIK 0001737127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,390 Underlying: Common Stock · 10,000 shares Expires 2022-05-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option is fully vested and exercisable. Read SEC document |
| September 12, 2019 Filed Sep 16, 2019 20:48 UTC |
Ban RandyChief Commercial Officer
|
SaleCommon Stock | 500 | $63.01 | $31,505.00 |
DisclosureSEC source: 0001104659-19-050284 · a4.xml · nonDerivative · entry 4 Ban Randy · CIK 0001737127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 900 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| September 12, 2019 Filed Sep 16, 2019 20:48 UTC |
Ban RandyChief Commercial Officer
|
SaleCommon Stock | 2,582 | $62.04 | $160,187.28 |
DisclosureSEC source: 0001104659-19-050284 · a4.xml · nonDerivative · entry 3 Ban Randy · CIK 0001737127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,400 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $62.01 to $62.46. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 12, 2019 Filed Sep 16, 2019 20:48 UTC |
Ban RandyChief Commercial Officer
|
SaleCommon Stock | 6,918 | $61.36 | $424,488.48 |
DisclosureSEC source: 0001104659-19-050284 · a4.xml · nonDerivative · entry 2 Ban Randy · CIK 0001737127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,982 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.01 to $61.88. The reporting person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 12, 2019 Filed Sep 16, 2019 20:48 UTC |
Ban RandyChief Commercial Officer
|
Exercise / conversionCommon Stock | 10,000 | $1.47 | $14,700.00 |
DisclosureSEC source: 0001104659-19-050284 · a4.xml · nonDerivative · entry 1 Ban Randy · CIK 0001737127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,900 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 09, 2019 Filed Sep 11, 2019 20:15 UTC |
NELSON MARILYN CDirector
|
SaleCommon Stock | 1,200 | $68.08 | $81,696.00 |
DisclosureSEC source: 0001104659-19-049750 · a4.xml · nonDerivative · entry 3 NELSON MARILYN C · CIK 0001199894 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 300,517 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F3 · ownership.nature: Shares held by GDN Holdings, LLC, of which the Reporting Person is the managing member. Read SEC document |
| September 09, 2019 Filed Sep 11, 2019 20:15 UTC |
NELSON MARILYN CDirector
|
SaleCommon Stock | 25,000 | $67.36 | $1,684,000.00 |
DisclosureSEC source: 0001104659-19-049750 · a4.xml · nonDerivative · entry 2 NELSON MARILYN C · CIK 0001199894 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 301,717 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $67.00 to $67.95. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: Shares held by GDN Holdings, LLC, of which the Reporting Person is the managing member. Read SEC document |
| September 09, 2019 Filed Sep 11, 2019 20:15 UTC |
NELSON MARILYN CDirector
|
SaleCommon Stock | 33,800 | $66.18 | $2,236,884.00 |
DisclosureSEC source: 0001104659-19-049750 · a4.xml · nonDerivative · entry 1 NELSON MARILYN C · CIK 0001199894 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 326,717 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $66.00 to $66.94. The Reporting Person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: Shares held by GDN Holdings, LLC, of which the Reporting Person is the managing member. Read SEC document |
| September 06, 2019 Filed Sep 10, 2019 20:22 UTC |
Herbert Timothy P.Director · CEO and President
|
SaleCommon Stock | 10,000 | $70.00 | $700,000.00 |
DisclosureSEC source: 0001104659-19-049544 · a4.xml · nonDerivative · entry 1 Herbert Timothy P. · CIK 0001737136 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Indirect · By family trust Disclosed balance after: 79,624 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F2 · ownership.nature: Shares held by the Timothy P. Herbert 2013 Family Irrevocable GST Trust U/A/D November 27, 2013. Read SEC document |
| September 03, 2019 Filed Sep 5, 2019 20:16 UTC |
Herbert Timothy P.Director · CEO and President
|
SaleCommon Stock | 183 | $69.65 | $12,745.95 |
DisclosureSEC source: 0001104659-19-048924 · a4.xml · nonDerivative · entry 4 Herbert Timothy P. · CIK 0001737136 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Indirect · By family trust Disclosed balance after: 89,624 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $69.64 to $69.66. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: Shares held by the Timothy P. Herbert 2013 Family Irrevocable GST Trust U/A/D November 27, 2013. Read SEC document |
| September 03, 2019 Filed Sep 5, 2019 20:16 UTC |
Herbert Timothy P.Director · CEO and President
|
SaleCommon Stock | 1,846 | $68.48 | $126,414.08 |
DisclosureSEC source: 0001104659-19-048924 · a4.xml · nonDerivative · entry 3 Herbert Timothy P. · CIK 0001737136 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Indirect · By family trust Disclosed balance after: 89,807 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $68.17 to $68.95. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: Shares held by the Timothy P. Herbert 2013 Family Irrevocable GST Trust U/A/D November 27, 2013. Read SEC document |
| September 03, 2019 Filed Sep 5, 2019 20:16 UTC |
Herbert Timothy P.Director · CEO and President
|
SaleCommon Stock | 2,472 | $67.44 | $166,711.68 |
DisclosureSEC source: 0001104659-19-048924 · a4.xml · nonDerivative · entry 2 Herbert Timothy P. · CIK 0001737136 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Indirect · By family trust Disclosed balance after: 91,653 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $67.05 to $68.01. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: Shares held by the Timothy P. Herbert 2013 Family Irrevocable GST Trust U/A/D November 27, 2013. Read SEC document |
| September 03, 2019 Filed Sep 5, 2019 20:16 UTC |
Herbert Timothy P.Director · CEO and President
|
SaleCommon Stock | 5,499 | $66.56 | $366,013.44 |
DisclosureSEC source: 0001104659-19-048924 · a4.xml · nonDerivative · entry 1 Herbert Timothy P. · CIK 0001737136 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Indirect · By family trust Disclosed balance after: 94,125 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $66.04 to $67.03. The reporting person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: Shares held by the Timothy P. Herbert 2013 Family Irrevocable GST Trust U/A/D November 27, 2013. Read SEC document |
| August 27, 2019 Filed Aug 28, 2019 20:15 UTC |
Herbert Timothy P.Director · CEO and President
|
SaleCommon Stock | 2,363 | $67.22 | $158,840.86 |
DisclosureSEC source: 0001104659-19-047728 · a4.xml · nonDerivative · entry 3 Herbert Timothy P. · CIK 0001737136 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Indirect · By family trust Disclosed balance after: 99,624 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $67.08 to $67.39. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: Shares held by the Timothy P. Herbert 2013 Family Irrevocable GST Trust U/A/D November 27, 2013. Read SEC document |
| August 27, 2019 Filed Aug 28, 2019 20:15 UTC |
Herbert Timothy P.Director · CEO and President
|
SaleCommon Stock | 3,155 | $66.47 | $209,712.85 |
DisclosureSEC source: 0001104659-19-047728 · a4.xml · nonDerivative · entry 2 Herbert Timothy P. · CIK 0001737136 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Indirect · By family trust Disclosed balance after: 101,987 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.98 to $66.93. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: Shares held by the Timothy P. Herbert 2013 Family Irrevocable GST Trust U/A/D November 27, 2013. Read SEC document |
| August 27, 2019 Filed Aug 28, 2019 20:15 UTC |
Herbert Timothy P.Director · CEO and President
|
SaleCommon Stock | 9,482 | $65.47 | $620,786.54 |
DisclosureSEC source: 0001104659-19-047728 · a4.xml · nonDerivative · entry 1 Herbert Timothy P. · CIK 0001737136 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Indirect · By family trust Disclosed balance after: 105,142 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $64.94 to $65.92. The reporting person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: Shares held by the Timothy P. Herbert 2013 Family Irrevocable GST Trust U/A/D November 27, 2013. Read SEC document |
| August 21, 2019 Filed Aug 22, 2019 20:15 UTC |
Jain Mudit K.Director
|
SaleCommon Stock | 980 | $69.00 | $67,620.00 |
DisclosureSEC source: 0001104659-19-046959 · a4.xml · nonDerivative · entry 2 Jain Mudit K. · CIK 0001584404 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,370 Read SEC document |
| August 20, 2019 Filed Aug 22, 2019 20:15 UTC |
Jain Mudit K.Director
|
SaleCommon Stock | 270 | $68.51 | $18,497.70 |
DisclosureSEC source: 0001104659-19-046959 · a4.xml · nonDerivative · entry 1 Jain Mudit K. · CIK 0001584404 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,350 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $68.47 to $68.97. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 19, 2019 Filed Aug 20, 2019 20:28 UTC |
Jain Mudit K.Director
|
SaleCommon Stock | 750 | $67.80 | $50,850.00 |
DisclosureSEC source: 0001104659-19-046657 · a4.xml · nonDerivative · entry 4 Jain Mudit K. · CIK 0001584404 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,620 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $67.47 to $67.97. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 19, 2019 Filed Aug 20, 2019 20:28 UTC |
Jain Mudit K.Director
|
SaleCommon Stock | 1,000 | $66.77 | $66,770.00 |
DisclosureSEC source: 0001104659-19-046657 · a4.xml · nonDerivative · entry 3 Jain Mudit K. · CIK 0001584404 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,370 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $66.15 to $66.97. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 19, 2019 Filed Aug 20, 2019 20:28 UTC |
Buchholz RichardChief Financial Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 4,000 | $0.00 Strike: $2.07 | $0.00 |
DisclosureSEC source: 0001104659-19-046656 · a4.xml · derivative · entry 10 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,706 Underlying: Common Stock · 4,000 shares Expires 2024-05-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The option is fully vested and exercisable. Read SEC document |
| August 19, 2019 Filed Aug 20, 2019 20:28 UTC |
Buchholz RichardChief Financial Officer
|
SaleCommon Stock | 200 | $64.89 | $12,978.00 |
DisclosureSEC source: 0001104659-19-046656 · a4.xml · nonDerivative · entry 5 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,706 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| August 19, 2019 Filed Aug 20, 2019 20:28 UTC |
Buchholz RichardChief Financial Officer
|
SaleCommon Stock | 700 | $65.57 | $45,899.00 |
DisclosureSEC source: 0001104659-19-046656 · a4.xml · nonDerivative · entry 4 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,906 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.22 to $65.98. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 19, 2019 Filed Aug 20, 2019 20:28 UTC |
Buchholz RichardChief Financial Officer
|
SaleCommon Stock | 1,200 | $66.71 | $80,052.00 |
DisclosureSEC source: 0001104659-19-046656 · a4.xml · nonDerivative · entry 3 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,606 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $66.33 to $67.00. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 19, 2019 Filed Aug 20, 2019 20:28 UTC |
Buchholz RichardChief Financial Officer
|
SaleCommon Stock | 1,900 | $67.63 | $128,497.00 |
DisclosureSEC source: 0001104659-19-046656 · a4.xml · nonDerivative · entry 2 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,806 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $67.06 to $68.05. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 19, 2019 Filed Aug 20, 2019 20:28 UTC |
Buchholz RichardChief Financial Officer
|
Exercise / conversionCommon Stock | 4,000 | $2.07 | $8,280.00 |
DisclosureSEC source: 0001104659-19-046656 · a4.xml · nonDerivative · entry 1 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,706 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 16, 2019 Filed Aug 20, 2019 20:28 UTC |
Jain Mudit K.Director
|
SaleCommon Stock | 106 | $66.00 | $6,996.00 |
DisclosureSEC source: 0001104659-19-046657 · a4.xml · nonDerivative · entry 2 Jain Mudit K. · CIK 0001584404 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,370 Read SEC document |
| August 16, 2019 Filed Aug 20, 2019 20:28 UTC |
Jain Mudit K.Director
|
SaleCommon Stock | 384 | $65.38 | $25,105.92 |
DisclosureSEC source: 0001104659-19-046657 · a4.xml · nonDerivative · entry 1 Jain Mudit K. · CIK 0001584404 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,476 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.00 to $65.85. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 01, 2019 Filed Aug 5, 2019 20:15 UTC |
Herbert Timothy P.Director · CEO and President
|
SaleCommon Stock | 254 | $69.32 | $17,607.28 |
DisclosureSEC source: 0001104659-19-043932 · a4.xml · nonDerivative · entry 3 Herbert Timothy P. · CIK 0001737136 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Indirect · By family trust Disclosed balance after: 114,624 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F3 · ownership.nature: Shares held by the Timothy P. Herbert 2013 Family Irrevocable GST Trust U/A/D November 27, 2013. Read SEC document |
| August 01, 2019 Filed Aug 5, 2019 20:15 UTC |
Herbert Timothy P.Director · CEO and President
|
SaleCommon Stock | 6,794 | $68.29 | $463,962.26 |
DisclosureSEC source: 0001104659-19-043932 · a4.xml · nonDerivative · entry 2 Herbert Timothy P. · CIK 0001737136 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Indirect · By family trust Disclosed balance after: 114,878 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $67.79 to $68.68. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: Shares held by the Timothy P. Herbert 2013 Family Irrevocable GST Trust U/A/D November 27, 2013. Read SEC document |
| August 01, 2019 Filed Aug 5, 2019 20:15 UTC |
Herbert Timothy P.Director · CEO and President
|
SaleCommon Stock | 2,952 | $67.27 | $198,581.04 |
DisclosureSEC source: 0001104659-19-043932 · a4.xml · nonDerivative · entry 1 Herbert Timothy P. · CIK 0001737136 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Indirect · By family trust Disclosed balance after: 121,672 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $66.77 to $67.66. The reporting person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: Shares held by the Timothy P. Herbert 2013 Family Irrevocable GST Trust U/A/D November 27, 2013. Read SEC document |
| July 31, 2019 Filed Mar 6, 2020 23:16 UTC |
Ban RandyChief Commercial Officer
|
GrantStock Option (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $67.63 | $0.00 |
DisclosureSEC source: 0001104659-20-030294 · a4.xml · derivative · entry 10 Ban Randy · CIK 0001737127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2029-07-31 F8 · derivative.exercise_date: The option vests and becomes exercisable as to 25% of the underlying shares on the first anniversary of July 31, 2019 and the remaining 75% of the underlying shares in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates. Read SEC document |
| July 25, 2019 Filed Jul 29, 2019 20:15 UTC |
Ellis Gary LeeDirector
|
GrantStock Option (right to buy) · Derivative | 5,261 | $0.00 Strike: $67.75 | $0.00 |
DisclosureSEC source: 0001104659-19-042298 · a4.xml · derivative · entry 1 Ellis Gary Lee · CIK 0001290170 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,261 Underlying: Common Stock · 5,261 shares Expires 2029-07-25 F1 · derivative.exercise_date: The option vests and becomes exercisable in three equal annual installments beginning on July 25, 2020, subject to the Reporting Person's continuous service to the Issuer through the applicable vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.